Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

The trial evaluates THIO's safety, tolerability, and efficacy in combination with PD-(L)1 inhibition. THIO sequenced with Libtayo extended overall survival in those with non–small cell lung cancer who ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo ® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Wondering what typeface was used in any given video game? Charlotte Couderc's Game Font Library is exactly what it claims to be. You can search by game, genre, studio, typeface or even foundry. Game ...

Libtayo was the sixth PD-L/PD-L1 inhibitor to reach the market, starting out as a therapy for another skin cancer called cutaneous squamous cell carcinoma (CSCC), and the rarity of that disease ...

Sanofi and Regeneron have reported new data for Libtayo that suggests the drug could be a contender. Overall survival (OS) was 22 months with the combination, compared to 13 months with chemo on ...

The biggest stories of the day delivered to your inbox.

The Bulgari logo consists of the brand name in a very stylish and modern font. The first letter, “B”, is slightly larger than the rest, creating a sense of hierarchy and importance. The brand name is ...

The world of sans-serif fonts is rich and diverse. They've got the perfect blend of modern appeal and functionality. Whether crafting a sleek website or designing a logo, these options will elevate ...

A novel AI model was able to achieve 99.86% accuracy for diagnosing skin conditions, even in people with darker skin tones or excessive hair. A new artificial intelligence (AI) model designed to ...